Proteomics Services Business Continues to Prop Up Hybrigenics' Drug Development Efforts

For 2010 the company posted €3.54 million ($4.84 million) in service revenues, up 6 percent from €3.33 million the year before, while its pharma revenues dropped 55 percent to €400,000 from €900,000 in 2009.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.